Physician profile
Ryan Englis
NPI 1427600501
$1,110.84
in general payments reported to CMS, 2019-2025
23 companies · $15.94 in 2025
The $15.94 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $882 · 2022: $134 · 2023: $78.89 · 2025: $15.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $94.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $94.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmacyclics LLC, An Abbvie Company | $172.91 | 2021-2023 | Imbruvica |
| Seagen INC. | $124.02 | 2021 | |
| Novartis Pharmaceuticals Corporation | $97.13 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $91.35 | 2021 | |
| Myriad Genetic Laboratories, INC. | $83.89 | 2021 | |
| Amgen INC. | $62.22 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $56.09 | 2021 | |
| Pfizer INC. | $50.08 | 2021 | |
| Janssen Biotech, INC. | $42.57 | 2021-2022 | |
| Puma Biotechnology, INC. | $40.28 | 2021 | |
| Genentech USA, INC. | $36.01 | 2021 | |
| Eisai INC. | $34.75 | 2021 | |
| Beigene USA, INC. | $32.12 | 2021 | |
| Glaxosmithkline, LLC. | $30.23 | 2021 | |
| Daiichi Sankyo INC. | $28.91 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coherus Oncology, INC. | $22.64 | 2021 | |
| Acrotech Biopharma INC. | $19.82 | 2021 | |
| Siemens Medical Solutions USA, INC. | $16.67 | 2021 | |
| Abbvie INC. | $15.94 | 2025 | |
| Lilly USA, LLC | $15.29 | 2021 | |
| Emd Serono, INC. | $14.31 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $11.88 | 2021 | |
| Genzyme Corporation | $11.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Englis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.